CVRx Launches Next-Generation Barostim Neo2 Implantable Pulse Generator to Treat Heart Failure Symptoms

November 14, 2022—CVRx, Inc., developer of the FDA-approved Barostim neuromodulation device to treat the symptoms of heart failure, recently ann

Related Keywords

Georgia ,United States ,Piedmont Atlanta ,Barostim Neo ,Michael Hoosien ,Cvrx Barostim ,Cvrx Inc ,Barostim Programmer ,Heart Failure ,Neuromodulation ,Arostim ,Pg ,Implantable Pulse Generator ,Aroreflex ,Da Breakthrough ,Hypertension ,